Lumida
/IHI
⌘K
IHI

IHI

IHI
$50.88USD-0.04%-0.02 today

MARKET CAP

0

P/E (TTM)

FWD P/E

DAY RANGE

$50 – $52

52W RANGE

$47
$65

AI Summary

Stalk
Sell NowHigh

IHI is entrenched in a Stage 4 decline, trading below its 50-day and 200-day moving averages after a decisive support failure. Downward-sloping EMAs, a clear sequence of lower highs and lower lows, and lack of bullish or mean-reversion signals reinforce a medium-term bearish posture. Short-term price action is extended below EMAs with volume favoring sell-offs, supporting immediate participation on rallies into the broken support cluster. Only a sustained reclaim and acceptance above key EMAs and the resistance zone would invalidate this bearish bias.

  • Trading at $54.08, ~20.7% discount vs GF Value $68.19
  • GF Score of 84 signals robust financial health and growth potential
  • Stochastic Oscillator overbought with weak momentum factors, raising pullback risk
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

The iShares U.S. Medical Devices ETF (IHI) is a well-established exchange-traded fund that seeks to track the performance of companies engaged in the medical devices, instruments, and supplies industry within the U.S. healthcare sector. The ETF includes large-cap players that dominate the medical devices market, leveraging technological advancements and innovation. The current focus of IHI aligns with the ongoing rise in healthcare spending and the increasing adoption of advanced medical technologies, positioning it favorably in the context of optimizing patient care and healthcare delivery.

Bull says

  • Trading at $54.08, ~20.7% discount vs GF Value $68.19
  • GF Score of 84 signals robust financial health and growth potential
  • Forecasted to reach $60.59 in 52 weeks, implying ~12% upside
  • Technical indicators hint at imminent breakout and strong momentum factors
  • Sector rally and rising healthcare spending underpin demand for medical devices

Bear says

  • Stochastic Oscillator overbought with weak momentum factors, raising pullback risk
  • Broader market volatility and potential rate hikes could pressure healthcare ETFs
  • Short-term euphoria risks inflated valuations and subsequent profit-taking
  • Economic headwinds may dampen healthcare budgets and ETF flows
  • Rapid tech disruption demands constant innovation, posing execution risk

Investment themes with IHI

Health Care Equipment & Supplies +0.40%

Clinical instruments and devices powering patient care

ABT · ISRG · SYK